Haptoglobin enhances cardiac transplant rejection

Circulation Research

Volumn 116, Issue 10, 2015, Pages 1670-1679

  Shen, Hua ^a   Heuzey, Elizabeth ^a   Mori, Daniel N ^a   Wong, Christine K ^a   Colangelo, Christopher M ^a   Chung, Lisa M ^a   Bruce, Can ^a,b   Slizovskiy, Ilya B ^a   Booth, Carmen J ^a   Kreisel, Daniel ^c   Goldstein, Daniel R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sciomix   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunology; Inflammation; Rejection; Transplantation

Indexed keywords

ABATACEPT; CALGRANULIN A; CHITINASE; CXCL3 CHEMOKINE; HAPTOGLOBIN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) TRANSHYDROGENASE; VIMENTIN; ANTIBODY CONJUGATE; AUTACOID; CXCL2 CHEMOKINE; CXCL2 PROTEIN, MOUSE; GAMMA INTERFERON; HP PROTEIN, HUMAN; IL10 PROTEIN, MOUSE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN-6, MOUSE; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; DENDRITIC CELL; GRAFT SURVIVAL; HEART; HEART TRANSPLANTATION; IN VITRO STUDY; ISOGRAFT; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; ADVERSE EFFECTS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; DEFICIENCY; DISEASE MODEL; FEMALE; GENETICS; GRAFT REJECTION; HEART MUSCLE; HUMAN; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; PATHOLOGY; PROCEDURES; PROTEOMICS; T LYMPHOCYTE; TIME;

ABATACEPT; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL2; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; GRAFT REJECTION; HAPTOGLOBINS; HEART TRANSPLANTATION; HUMANS; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MALE; MASS SPECTROMETRY; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; MYOCARDIUM; PROTEOMICS; T-LYMPHOCYTES; TIME FACTORS;

EID: 84942882536     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.305406     Document Type: Article

References (32)

1. Rock KL, Hearn A, Chen CJ, Shi Y., Natural endogenous adjuvants. Springer Semin Immunopathol 2005; 26: 231-246. doi: 10.1007/s00281-004-0173-3
2. Shen H, Kreisel D, Goldstein DR., Processes of sterile inflammation. J Immunol 2013; 191: 2857-2863. doi: 10.4049/jimmunol.1301539
3. Chen GY, G. N., Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol 2010 12 826 837
4. Eltzschig HK, Eckle T., Ischemia and reperfusion-from mechanism to translation. Nat Med 2011; 17: 1391-1401. doi: 10.1038/nm.2507
5. Wu H, Chadban SJ., Roles of Toll-like receptors in transplantation. Curr Opin Organ Transplant 2014; 19: 1-7. doi: 10.1097/MOT.0000000000000038
6. Wells A, Larsson E, Hanás E, Laurent T, Hällgren R, Tufveson G., Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 1993 55 1346 1349
7. Pockley AG., Heat shock proteins, anti-heat shock protein reactivity and allograft rejection. Transplantation 2001 71 1503 1507
8. Huang Y, Yin H, Han J, Huang B, Xu J, Zheng F, Tan Z, Fang M, Rui L, Chen D, Wang S, Zheng X, Wang CY, Gong F., Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 2007; 7: 799-808. doi: 10.1111/j.1600-6143.2007.01734.x
9. Chong AS, Alegre ML., The impact of infection and tissue damage in solid-organ transplantation. Nat Rev Immunol 2012; 12: 459-471. doi: 10.1038/nri3215
10. Corry RJ, Winn HJ, Russell PS., Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973 16 343 350
11. Shen H, Song Y, Colangelo CM, Wu T, Bruce C, Scabia G, Galan A, Maffei M, Goldstein DR., Haptoglobin activates innate immunity to enhance acute transplant rejection in mice. J Clin Invest 2012; 122: 383-387. doi: 10.1172/JCI58344
12. Stewart S, Winters GL, Fishbein MC, Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710-1720. doi: 10.1016/j.healun.2005.03.019
13. Floerchinger B, Oberhuber R, Tullius SG., Effects of brain death on organ quality and transplant outcome. Transplant Rev (Orlando) 2012; 26: 54-59. doi: 10.1016/j.trre.2011.10.001
14. Lei J, He F, Wu M, Zheng X, Chen X, Chen Z., Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival. Transpl Int 2010; 23: 1271-1281. doi: 10.1111/j.1432-2277.2010.01125.x
15. Zhao X, Boenisch O, Yeung M, Mfarrej B, Yang S, Turka LA, Sayegh MH, Iacomini J, Yuan X., Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am J Transplant 2012; 12: 90-101. doi: 10.1111/j.1600-6143.2011.03770.x
16. Liang Y, Christopher K, Finn PW, Colson YL, Perkins DL., Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation. Transplantation 2007; 84: 771-777. doi: 10.1097/01.tp.0000281384.24333.0b
17. Quaye IK., Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 2008; 102: 735-742. doi: 10.1016/j.trstmh.2008.04.010
18. Huntoon KM, Wang Y, Eppolito CA, Barbour KW, Berger FG, Shrikant PA, Baumann H., The acute phase protein haptoglobin regulates host immunity. J Leukoc Biol 2008; 84: 170-181. doi: 10.1189/jlb.0208100
19. Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC., Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 2004; 94: 119-126. doi: 10.1161/01.RES.0000109414.78907.F9
20. Vincenti F, Blancho G, Durrbach A, Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol 2010; 21: 1587-1596. doi: 10.1681/ASN.2009111109
21. Schaer CA, Schoedon G, Imhof A, Kurrer MO, Schaer DJ., Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ Res 2006; 99: 943-950. doi: 10.1161/01.RES.0000247067.34173.1b
22. Kreisel D, Krasinskas AM, Krupnick AS, Gelman AE, Balsara KR, Popma SH, Riha M, Rosengard AM, Turka LA, Rosengard BR., Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection. J Immunol 2004 173 3027 3034
23. Oberbarnscheidt MH, Zeng Q, Li Q, Dai H, Williams AL, Shlomchik WD, Rothstein DM, Lakkis FG., Non-self recognition by monocytes initiates allograft rejection. J Clin Invest 2014; 124: 3579-3589. doi: 10.1172/JCI74370
24. Shen H, Tesar BM, Walker WE, Goldstein DR., Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation. J Immunol 2008 181 1849 1858
25. Arredouani M, Matthijs P, Van Hoeyveld E, Kasran A, Baumann H, Ceuppens JL, Stevens E., Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 2003 108 144 151
26. Li P, Gao XH, Chen HD, Zhang Y, Wang Y, Wang H, Wang Y, Xie Y., Localization of haptoglobin in normal human skin and some skin diseases. Int J Dermatol 2005; 44: 280-284. doi: 10.1111/j.1365-4632.2005.02088.x
27. Arredouani MS, Kasran A, Vanoirbeek JA, Berger FG, Baumann H, Ceuppens JL., Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology 2005; 114: 263-271. doi: 10.1111/j.1365-2567.2004.02071.x
28. Arslan F, Smeets MB, Buttari B, Profumo E, Riganò R, Akeroyd L, Kara E, Timmers L, Sluijter JP, van Middelaar B, den Ouden K, Pasterkamp G, Lim SK, de Kleijn DP., Lack of haptoglobin results in unbalanced VEGFα/angiopoietin-1 expression, intramural hemorrhage and impaired wound healing after myocardial infarction. J Mol Cell Cardiol 2013; 56: 116-128. doi: 10.1016/j.yjmcc.2012.12.012
29. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ., TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859. doi: 10.1172/JCI31008
30. Shimizu K, Libby P, Rocha VZ, Folco EJ, Shubiki R, Grabie N, Jang S, Lichtman AH, Shimizu A, Hogg N, Simon DI, Mitchell RN, Croce K., Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection. Circulation 2011; 124: 2920-2932. doi: 10.1161/CIRCULATIONAHA.110.009910
31. Schmidt IM, Hall IE, Kale S, Lee S, He CH, Lee Y, Chupp GL, Moeckel GW, Lee CG, Elias JA, Parikh CR, Cantley LG., Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function. J Am Soc Nephrol 2013; 24: 309-319. doi: 10.1681/ASN.2012060579
32. Rose ML., Role of anti-vimentin antibodies in allograft rejection. Hum Immunol 2013; 74: 1459-1462. doi: 10.1016/j.humimm.2013.06.006